Showing results (1-10 of 110) with videos related to
Sort By:
Pageof 11
The Surgical Clinics of North America|July 15, 2018
Future Developments in Neoadjuvant Therapy for Triple-Negative Breast CancerLakisha Moore-Smith, Andres Forero-Torres, Erica Stringer-ReasorClinical Advances in Hematology & Oncology : H&O|May 13, 2024
Increasing inclusion and equity for Black women in breast cancer clinical trialsAmmanuel Taye, Ahmed Elkhanany, Erica Stringer-ReasorJournal of Mammary Gland Biology and Neoplasia|April 5, 2011
TGFBR1 signaling and breast cancerLakisha Moore-Smith, Boris PascheCurrent Treatment Options in Oncology|November 4, 2011
How do I treat "triple-negative" diseaseChristos Vaklavas, Andres Forero-TorresTherapeutic Advances in Hematology|April 23, 2013
Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphomaChristos Vaklavas, Andres Forero-TorresCurrent Oncology Reports|July 22, 2015
Development and Integration of Antibody-Drug Conjugate in Non-Hodgkin LymphomaAmitkumar Mehta, Andres Forero-TorresClinical Lymphoma & Myeloma|March 8, 2008
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold WarAndres Forero-Torres, Mansoor N SalehFuture Oncology (London, England)|July 31, 2007
TRAIL-receptor antibodies as a potential cancer treatmentDonald J Buchsbaum, Andres Forero-Torres, Albert F LoBuglioLeukemia & Lymphoma|December 30, 2009
A phase I study of dacetuzumab (SGN-40, a humanized anti-CD40 monoclonal antibody) in patients with chronic lymphocytic leukemiaRichard R Furman, Andres Forero-Torres, Andrei Shustov, et al.Ultrasound in Medicine & Biology|June 28, 2015
Ultrasound imaging of breast tumor perfusion and neovascular morphologyKenneth Hoyt, Heidi Umphrey, Mark Lockhart, et al.Pageof 11